These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 26206949

  • 21. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC.
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
    [Abstract] [Full Text] [Related]

  • 22. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP, Xiao ZL, Yang Z, Li J, Feng GX, Chen FQ, Li YH, Feng JY, Gao YE, Ye LH, Zhang XD.
    Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
    [Abstract] [Full Text] [Related]

  • 23. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma.
    Lee WP, Lan KH, Li CP, Chao Y, Lin HC, Lee SD.
    Biochim Biophys Acta; 2016 Apr; 1862(4):837-849. PubMed ID: 26791804
    [Abstract] [Full Text] [Related]

  • 24. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E.
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [Abstract] [Full Text] [Related]

  • 25. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
    Su JC, Chiang HC, Tseng PH, Tai WT, Hsu CY, Li YS, Huang JW, Ko CH, Lin MW, Chu PY, Liu CY, Chen KF, Shiau CW.
    Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
    Chen S, Dong Z, Yang P, Wang X, Jin G, Yu H, Chen L, Li L, Tang L, Bai S, Yan H, Shen F, Cong W, Wen W, Wang H.
    Cancer Lett; 2017 May 28; 394():22-32. PubMed ID: 28216372
    [Abstract] [Full Text] [Related]

  • 27. A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy.
    Chao TI, Tai WT, Hung MH, Tsai MH, Chen MH, Chang MJ, Shiau CW, Chen KF.
    Cancer Lett; 2016 Feb 28; 371(2):205-13. PubMed ID: 26679051
    [Abstract] [Full Text] [Related]

  • 28. The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.
    Xu J, Lin H, Li G, Sun Y, Chen J, Shi L, Cai X, Chang C.
    EBioMedicine; 2016 Oct 28; 12():55-67. PubMed ID: 27688096
    [Abstract] [Full Text] [Related]

  • 29. Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.
    Tai WT, Shiau CW, Chen PJ, Chu PY, Huang HP, Liu CY, Huang JW, Chen KF.
    Hepatology; 2014 Jan 28; 59(1):190-201. PubMed ID: 23908138
    [Abstract] [Full Text] [Related]

  • 30. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
    Chen JY, Chen YJ, Yen CJ, Chen WS, Huang WC.
    Oncotarget; 2016 Jan 05; 7(1):473-89. PubMed ID: 26595522
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression.
    Zhang Y, Liu H, Yi R, Yan T, He Y, Zhao Y, Liu J.
    J Exp Clin Cancer Res; 2016 Jun 03; 35(1):87. PubMed ID: 27255760
    [Abstract] [Full Text] [Related]

  • 32. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Na TY, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ, Seong JK, Park CK, Choi YL, Lee MO.
    Hepatology; 2009 Apr 03; 49(4):1122-31. PubMed ID: 19105208
    [Abstract] [Full Text] [Related]

  • 33. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
    Zhu M, Li W, Lu Y, Dong X, Lin B, Chen Y, Zhang X, Guo J, Li M.
    Int J Cancer; 2017 Mar 15; 140(6):1346-1355. PubMed ID: 27925189
    [Abstract] [Full Text] [Related]

  • 34. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R, Mok MT, Kang W, Lau SS, Yip WK, Chen Y, Lai PB, Wong VW, To KF, Sung JJ, Cheng AS, Chan HL.
    J Pathol; 2015 Sep 15; 237(1):38-49. PubMed ID: 25925944
    [Abstract] [Full Text] [Related]

  • 35. Hepatitis B virus X reduces hepatocyte apoptosis and promotes cell cycle progression through the Akt/mTOR pathway in vivo.
    Wang X, Huo B, Liu J, Huang X, Zhang S, Feng T.
    Gene; 2019 Apr 05; 691():87-95. PubMed ID: 30630095
    [Abstract] [Full Text] [Related]

  • 36. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
    Tang Y, Zhang Y, Wang C, Sun Z, Li L, Dong J, Zhou W.
    Cancer Med; 2018 Nov 05; 7(11):5543-5553. PubMed ID: 30358169
    [Abstract] [Full Text] [Related]

  • 37. Intracellular antibody targeting HBx suppresses invasion and metastasis in hepatitis B virus-related hepatocarcinogenesis via protein phosphatase 2A-B56γ-mediated dephosphorylation of protein kinase B.
    Che L, Du ZB, Wang WH, Wu JS, Han T, Chen YY, Han PY, Lei Z, Chen XX, He Y, Xu L, Lin X, Lin ZN, Lin YC.
    Cell Prolif; 2022 Nov 05; 55(11):e13304. PubMed ID: 35811356
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein.
    Hu JL, Liu LP, Yang SL, Fang X, Wen L, Ren QG, Yu C.
    Oncol Rep; 2016 Mar 05; 35(3):1443-8. PubMed ID: 26647960
    [Abstract] [Full Text] [Related]

  • 39. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
    Huang CY, Tai WT, Hsieh CY, Hsu WM, Lai YJ, Chen LJ, Shiau CW, Chen KF.
    Cancer Lett; 2014 Jul 28; 349(2):136-43. PubMed ID: 24735751
    [Abstract] [Full Text] [Related]

  • 40. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.
    Xu J, Yun X, Jiang J, Wei Y, Wu Y, Zhang W, Liu Y, Wang W, Wen Y, Gu J.
    Hepatology; 2010 Jul 28; 52(1):142-54. PubMed ID: 20578140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.